Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wenker

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nuclear Medicine and Biology|September 20, 2022
Biologicals as theranostic vehicles in paediatric oncologyVeerle J A Niessen, Sylvia T M Wenker, Marnix G E H Lam, et al.
Antimicrobial Agents and Chemotherapy|June 18, 2026
A novel hollow-fiber infection model (HFIM) for antiviral PK/PD studies of CMV infectionLalitya M Sudarsono, Suzanne A M Wenker, Xuanlin Liu, et al.
Jac-Antimicrobial Resistance|March 13, 2024
Defining the pharmacokinetic/pharmacodynamic index of piperacillin/tazobactam within a hollow-fibre infection model to determine target attainment in intensive care patientsSuzanne A M Wenker, Najla Alabdulkarim, John B Readman, et al.
Journal of Personalized Medicine|April 30, 2021
Nuclear Medicine Imaging in Neuroblastoma: Current Status and New DevelopmentsAtia Samim, Godelieve A M Tytgat, Gitta Bleeker, et al.
Theranostics|March 9, 2026
CAIX-targeted α therapy directed against hypoxic tumor cells in combination with immune checkpoint inhibitors in a syngeneic mouse tumor modelSylvia T M Wenker, Mark W Konijnenberg, Daphne Lobeek, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nuclear Medicine and Biology|September 20, 2022
Biologicals as theranostic vehicles in paediatric oncologyVeerle J A Niessen, Sylvia T M Wenker, Marnix G E H Lam, et al.
Antimicrobial Agents and Chemotherapy|June 18, 2026
A novel hollow-fiber infection model (HFIM) for antiviral PK/PD studies of CMV infectionLalitya M Sudarsono, Suzanne A M Wenker, Xuanlin Liu, et al.
Jac-Antimicrobial Resistance|March 13, 2024
Defining the pharmacokinetic/pharmacodynamic index of piperacillin/tazobactam within a hollow-fibre infection model to determine target attainment in intensive care patientsSuzanne A M Wenker, Najla Alabdulkarim, John B Readman, et al.
Journal of Personalized Medicine|April 30, 2021
Nuclear Medicine Imaging in Neuroblastoma: Current Status and New DevelopmentsAtia Samim, Godelieve A M Tytgat, Gitta Bleeker, et al.
Theranostics|March 9, 2026
CAIX-targeted α therapy directed against hypoxic tumor cells in combination with immune checkpoint inhibitors in a syngeneic mouse tumor modelSylvia T M Wenker, Mark W Konijnenberg, Daphne Lobeek, et al.
Pageof 2